Quest Laboratories Ltd vs Samrat Pharmachem Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of Quest Laboratories Ltd is ₹ 151.65 as of 30 Apr 15:30 . The P/E Ratio of Quest Laboratories Ltd changed from 12.4 on March 2025 to 12.4 on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Samrat Pharmachem Ltd changed from 7.9 on March 2021 to 13.6 on March 2025 . This represents a CAGR of 11.48% over 5 years The Market Cap of Quest Laboratories Ltd changed from ₹ 167.89 crore on March 2025 to ₹ 167.89 crore on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Samrat Pharmachem Ltd changed from ₹ 42.02 crore on March 2021 to ₹ 96.63 crore on March 2025 . This represents a CAGR of 18.12% over 5 years The revenue of Quest Laboratories Ltd for the Dec '25 is ₹ 31.18 crore as compare to the Sep '25 revenue of ₹ 27.04 crore. This represent the growth of 15.31% The revenue of Samrat Pharmachem Ltd for the Dec '25 is ₹ 63.83 crore as compare to the Sep '25 revenue of ₹ 78.92 crore. This represent the decline of -19.12% The ebitda of Quest Laboratories Ltd for the Dec '25 is ₹ 7.48 crore as compare to the Sep '25 ebitda of ₹ 4.81 crore. This represent the growth of 55.51% The ebitda of Samrat Pharmachem Ltd for the Dec '25 is ₹ -0.26 crore as compare to the Sep '25 ebitda of ₹ -0.31 crore. This represent the decline of -16.13% The net profit of Quest Laboratories Ltd changed from ₹ 1.48 crore to ₹ 4.03 crore over 7 quarters. This represents a CAGR of 77.25% The net profit of Samrat Pharmachem Ltd changed from ₹ 2.07 crore to ₹ -0.46 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Quest Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Samrat Pharmachem Ltd changed from 1.8 % on March 2022 to 4.35 % on March 2025 . This represents a CAGR of 24.68% over 4 years .

About Quest Laboratories Ltd

Quest Laboratories Limited was originally incorporated as 'Quest Laboratories Private Limited' vide Certificate of Incorporation dated June 01, 1998, with the Registrar of Companies, Gwalior.
Thereafter, the status of the Company changed to Public Limited and the name of Company was changed to 'Quest Laboratories Limited' vide fresh Certificate of Incorporation issued on January 23, 2024, by Centralised Processing Centre. The Company is engaged in manufacturing of pharmaceutical formulations including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more.
It produces a variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC).
The Company is an ISO 9001:2015 in accordance with the requirements Quality Management System standard.

About Samrat Pharmachem Ltd

Samrat Pharmachem Limited was incorporated on June 16, 1992 at Ankleshwar in Gujarat led by the Promoters, Mr. Lalit Mehta & Mr. Rajesh Mehta.
Since then, it envisioned to focus on lodine Derivatives as their core products.
The Company's principal activities are manufacturing and selling chemicals.
Company is a producer of pharmaceutical chemicals.
The intermediates produced are used in pharmaceutical and chemical industries.

FAQs for the comparison of Quest Laboratories Ltd and Samrat Pharmachem Ltd

Which company has a larger market capitalization, Quest Laboratories Ltd or Samrat Pharmachem Ltd?

Market cap of Quest Laboratories Ltd is 248 Cr while Market cap of Samrat Pharmachem Ltd is 65 Cr

What are the key factors driving the stock performance of Quest Laboratories Ltd and Samrat Pharmachem Ltd?

The stock performance of Quest Laboratories Ltd and Samrat Pharmachem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Quest Laboratories Ltd and Samrat Pharmachem Ltd?

As of May 3, 2026, the Quest Laboratories Ltd stock price is INR ₹151.65. On the other hand, Samrat Pharmachem Ltd stock price is INR ₹211.1.

How do dividend payouts of Quest Laboratories Ltd and Samrat Pharmachem Ltd compare?

To compare the dividend payouts of Quest Laboratories Ltd and Samrat Pharmachem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.